SEARCH

SEARCH BY CITATION

References

  • 1
    Cecka JM. The OPTN/UNOS renal transplant registry. In: JM CeckaPT, ed. Clinical Transplants 2004, Los Angeles : UCLA Immunogenetics Center, 2004: 116.
  • 2
    Edwards LB, Keck BM. Thoracic organ transplantation in the US. In: CeckaJ, TerasakiPI, eds. Clinical Transplants 2002. Los Angeles : UCLA, 2003: 2940.
  • 3
    Smith CM, Davies DB, McBride MA. Liver transplantation in the United States: A report from the organ procurement and transplantation network. In: CeckaJ, TerasakiPI, eds. Clinical Transplants 2000. Los Angeles : UCLA, 2001: 1930.
  • 4
    Yen E, Hardinger K, Brennan DC et al. Cost-effectiveness of extending medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 2004; 4:17031708.
  • 5
    U.S. RDS. USRDS 2005 annual data report: Atlas of End Stage Renal Disease in the United States. Bethesda , MD : National Institutes of Health , 2005.
  • 6
    Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy—the concept of accelerated senescence. J Am Soc Nephrol 1999; 10:167181.
  • 7
    Halloran PF. Call for revolution: A new approach to describing allograft deterioration. Am J Transplant 2002; 2: 195200.
  • 8
    Terasaki PI, Ozawa M. Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial. Transplantation 2005; 80: 11941197.
  • 9
    Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci 1994; 91: 62596263.
  • 10
    Zwirner NW, Marcos CY, Mirbaha F, Zou Y, Stastny P. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000; 61: 917924.
  • 11
    Sumitran-Holgersson S, Wilczek HE, Holgersson J, Soderstrom K. Identification of the nonclassical HLA molecules, MICA, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002; 74: 268277.
  • 12
    Mizutani K, Terasaki P, Rosen A et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 2005; 5: 22652272.
  • 13
    Zou Y, Heinemann FM, Grosse-Wilde H et al. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol 2006; 67: 230237.
  • 14
    Mizutani K, Terasaki PI, Shih R, Pei R, Ozawa M, Lee J. Frequency of MICA antibody in rejected renal transplant patients without HLA antibody. Hum Immunol 2006; 67: 223229.
  • 15
    Lee PC, Terasaki PI, Takemoto SK et al. All chronic rejection failures of kidney transplants preceded by development of HLA antibodies. Transplantation 2002; 74: 11921194.
  • 16
    Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: A prospective trial. Am J Transplant 2004; 4: 438443.
  • 17
    Sumitran-Karuppan S, Tyden G, Reinholt F, Berg U, Moller E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997; 5: 321327.
  • 18
    Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003; 75: 4349.
  • 19
    El-Awar N, Lee J, Terasaki PI. HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 2005; 66: 989997.
  • 20
    Terasaki PI, Cai J. Humoral theory of transplantation: Further evidence. Curr Opin Immunol 2005; 17: 541545.
  • 21
    Rifle G, Mousson C, Martin L, Guignier F, Hajji K. Donor-specific antibodies in allograft rejection: Clinical and experimental data. Transplantation 2005; 79: S14S18.
  • 22
    Martin L, Guignier F, Mousson C, Rageot D, Justrabo E, Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003; 76: 395400.
  • 23
    Adeyi OA, Girnita AL, Howe J et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transplant Immunol 2005; 14: 5362.
  • 24
    Terasaki PI. Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants. Clin Transpl 2003: 449452.
  • 25
    Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365: 15701576.
  • 26
    Spierings E, Goulmy E. Expanding the immunotherapeutic potential of minor histocompatibility antigens. J Clin Invest 2005; 115: 33973400.
  • 27
    Dadaglio G, Nelson CA, Deck MB, Petzold SJ, Unanue ER. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 1997; 6: 727738.